GSA CAPITAL PARTNERS LLP - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 227 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q2 2019. The put-call ratio across all filers is 0.94 and the average weighting 0.3%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q3 2022$529,000
-63.4%
7,769
-84.3%
0.07%
-61.3%
Q4 2021$1,444,000
-14.7%
49,327
-25.7%
0.18%
+5.2%
Q3 2021$1,692,000
+635.7%
66,402
+910.4%
0.17%
+561.5%
Q2 2021$230,000
-17.6%
6,572
+14.2%
0.03%
-31.6%
Q3 2019$279,000
+22.9%
5,756
+33.9%
0.04%
+65.2%
Q1 2019$227,000
+25.4%
4,298
-60.6%
0.02%
+130.0%
Q2 2016$181,00010,9000.01%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q2 2019
NameSharesValueWeighting ↓
Logos Global Management LP 850,000$46,869,0006.00%
Asymmetry Capital Management, L.P. 155,232$8,559,0005.50%
Grace Capital 124,749$6,878,0005.33%
Fernwood Investment Management, LLC 187,477$10,337,0004.88%
Perceptive Advisors 5,800,996$319,867,0004.67%
ArchPoint Investors 217,510$11,993,0003.83%
GREAT POINT PARTNERS LLC 655,676$36,154,0003.25%
Profit Investment Management, LLC 42,196$2,328,0001.44%
Bain Capital Public Equity Management II, LLC 381,868$21,056,0001.39%
Taylor Wealth Management Partners 52,597$2,900,0001.33%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders